REVIEW ARTICLE PUJ Primary Amoebic Meningoencephalitis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Inhibition of Fatty Acid Oxidation As a New Target to Treat Primary Amoebic Meningoencephalitis
EXPERIMENTAL THERAPEUTICS crossm Inhibition of Fatty Acid Oxidation as a New Target To Treat Primary Amoebic Meningoencephalitis Maarten J. Sarink,a Aloysius G. M. Tielens,a,b Annelies Verbon,a Robert Sutak,c Jaap J. van Hellemonda a Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, Netherlands Downloaded from bDepartment of Biochemistry and Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands cDepartment of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic ABSTRACT Primary amoebic meningoencephalitis (PAM) is a rapidly fatal infection caused by the free-living amoeba Naegleria fowleri. The amoeba migrates along the ol- factory nerve to the brain, resulting in seizures, coma, and, eventually, death. Previous research has shown that Naegleria gruberi, a close relative of N. fowleri, prefers lipids over glucose as an energy source. Therefore, we tested several already-approved inhibi- http://aac.asm.org/ tors of fatty acid oxidation alongside the currently used drugs amphotericin B and milte- fosine. Our data demonstrate that etomoxir, orlistat, perhexiline, thioridazine, and val- proic acid inhibited growth of N. gruberi. We then tested these compounds on N. fowleri and found etomoxir, perhexiline, and thioridazine to be effective growth inhibitors. Hence, not only are lipids the preferred food source for N. gruberi, but also oxidation of fatty acids seems to be essential for growth of N. fowleri. Inhibition of fatty acid oxida- tion could result in new treatment options, as thioridazine inhibits N. fowleri growth in concentrations that can be reached at the site of infection. It could also potentiate cur- rently used therapy, as checkerboard assays revealed synergy between miltefosine and on August 4, 2020 by guest etomoxir. -
The Intestinal Protozoa
The Intestinal Protozoa A. Introduction 1. The Phylum Protozoa is classified into four major subdivisions according to the methods of locomotion and reproduction. a. The amoebae (Superclass Sarcodina, Class Rhizopodea move by means of pseudopodia and reproduce exclusively by asexual binary division. b. The flagellates (Superclass Mastigophora, Class Zoomasitgophorea) typically move by long, whiplike flagella and reproduce by binary fission. c. The ciliates (Subphylum Ciliophora, Class Ciliata) are propelled by rows of cilia that beat with a synchronized wavelike motion. d. The sporozoans (Subphylum Sporozoa) lack specialized organelles of motility but have a unique type of life cycle, alternating between sexual and asexual reproductive cycles (alternation of generations). e. Number of species - there are about 45,000 protozoan species; around 8000 are parasitic, and around 25 species are important to humans. 2. Diagnosis - must learn to differentiate between the harmless and the medically important. This is most often based upon the morphology of respective organisms. 3. Transmission - mostly person-to-person, via fecal-oral route; fecally contaminated food or water important (organisms remain viable for around 30 days in cool moist environment with few bacteria; other means of transmission include sexual, insects, animals (zoonoses). B. Structures 1. trophozoite - the motile vegetative stage; multiplies via binary fission; colonizes host. 2. cyst - the inactive, non-motile, infective stage; survives the environment due to the presence of a cyst wall. 3. nuclear structure - important in the identification of organisms and species differentiation. 4. diagnostic features a. size - helpful in identifying organisms; must have calibrated objectives on the microscope in order to measure accurately. -
Primary Amoebic Meningoencephalitis Due to Naegleria Fowleri
56 Case report Primary amoebic meningoencephalitis due to Naegleria fowleri A. Angrup, L. Chandel, A. Sood, K. Thakur, S. C. Jaryal Department of Microbiology,Dr. Rajendra Prasad Government Medical College, Kangra at Tanda, Himachal Pradesh, Pin Code- 176001, India. Correspondence to: Dr. Archana Angrup, Department of Microbiology, Dr. Rajendra Prasad Government Medical College, Kangra, Tanda, Himachal Pradesh, Pin Code-176001, India. Phone no. 09418119222, Facsimile: 01892-267115 Email: [email protected] Abstract The genus Naegleria comprises of free living ameboflagellates found in soil and fresh water. More than 30 species have been isolated but only N. fowleri has been associated with human disease. N. fowleri causes primary amoebic meningoencephalitis (PAM), an acute, often fulminant infection of CNS. Here we report a rare and first case of PAM in an immunocompetent elderly patient from this part of the country. Amoeboid and flagellate forms of N. fowleri were detected in the direct microscopic examination of CSF and confirmed by flagellation test in distilled water, demonstrating plaques /clear areas on 1.5% non nutrient agar and its survival at 42°C. Keywords: Meningitis, Naegleria fowleri, primary amoebic meningoencephalitis Introduction of our knowledge, in India, only eight cases have been reported so far .1, 5-8 Infection of the central nervous system (CNS) in human We hereby report a rare case of PAM in elderly beings with free living amoebae is uncommon. Among the immunocompetent patient from the hilly state of Himachal many different genera of amoebae, Naegleria spp, Pradesh (H.P) in Northern India. Acanthamoeba spp and Balamuthia spp are primarily pathogenic to the CNS. -
UNIVERSITE DES ANTILLES Faculté Des Sciences Exactes Et Naturelles École Doctorale Pluridisciplinaire
UNIVERSITE DES ANTILLES Faculté des Sciences Exactes et Naturelles École Doctorale pluridisciplinaire Thèse de Doctorat En Physiologie-biologie des organismes-populations-interactions Mirna MOUSSA Les amibes libres pathogènes des eaux chaudes de la Guadeloupe, étude écologique, caractérisation moléculaire et prophylaxie des zones de baignade Sous la direction de : Jérôme GUERLOTTÉ, Professeur, Université des Antilles Antoine TALARMIN, Docteur, Institut Pasteur de la Guadeloupe Soutenue le 25 Septembre 2015 à l’Institut Pasteur de Guadeloupe N: Jury: GROS Olivier, Pr. Université des Antilles Président HÉCHARD Yann, Pr. Université de Poitiers Rapporteur YERA Hélène , MCU-PH Institut Cochin, Paris Rapporteur ALBINA Emmanuel, Dr. CIRAD Antilles Examinateur DESBOIS Nicole, Dr. CHU de Fort-de-France Examinateur GUERLOTTÉ Jérôme, Pr. Université des Antilles Examinateur 2 A ma famille et mes amis pour leur Amour et leur soutien au quotidien. Vous avez toujours su trouver les mots pour m’encourager dans les moments les plus difficiles. Je ne vous remercierai jamais assez pour tout ce que vous avez fait. Je pense à ma grand-mère en Syrie qui m’a appris la joie de vivre malgré les difficultés. 3 4 Remerciements Je souhaite tout d’abord exprimer ma profonde gratitude au Docteur Antoine Talarmin qui m’a permis de réaliser cette thèse au sein de l’Institut Pasteur de la Guadeloupe ainsi qu’au Professeur Jérôme Guerlotté qui m’a fait l’honneur d’être mon Directeur de thèse durant ces trois années. Je leur suis extrêmement reconnaissante de m’avoir fait confiance et de m’avoir donné des opportunités pour réussir dans ce domaine. Je les remercie pour leur patience, leurs conseils, leur soutien et leur disponibilité. -
Accomplishments 2013
National Center for Emerging and Zoonotic Infectious Diseases Accomplishments 2013 The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) works to improve public health at home and around the world by protecting people from • Foodborne and waterborne illnesses • Deadly diseases like Ebola, anthrax, and rabies • Infections spread by animals, mosquitoes, ticks, and fleas • Infections in healthcare facilities or drug-resistant threats • Illnesses that cross borders and affect refugees, immigrants, and travelers Responding to outbreaks in the United States and across the globe In fiscal year 2013 (FY 2013), NCEZID regularly received requests from states and other countries to assist in the investigation of local, national, and international outbreaks of infectious diseases, known as Epi-Aids (see examples in the boxes on the bottom of pages 2–7). In addition to participating in more than 35 Epi-Aids, NCEZID supported health departments’ response to a variety of outbreaks through epidemiologic investigations, phone consultations, and technical assistance. CDC maintains an up-to-date list of current outbreaks on its website. National Center for Emerging and Zoonotic Infectious Diseases Office of the Director CS241973-A National Center for Emerging and Zoonotic Infectious Diseases Protecting public water systems and the public from Naegleria fowleri (brain-eating ameba) infections After the death of a child staying in St. Bernard Parish, Louisiana, NCEZID laboratories confirmed the presence of the brain-eating ameba Naegleria fowleri in the parish’s treated public water system. NCEZID worked with state public health officials and the US Environmental Protection Agency to develop a plan to rid the system of the ameba and communicate with residents about steps they can take to protect themselves. -
Mitochondrial DNA
GBE Missing Genes, Multiple ORFs, and C-to-U Type RNA Editing in Acrasis kona (Heterolobosea, Excavata) Mitochondrial DNA Cheng-Jie Fu1,*, Sanea Sheikh1, Wei Miao2, Siv G.E. Andersson3, and Sandra L. Baldauf1,* 1Program in Systematic Biology, Department of Organismal Biology, Evolutionary Biology Centre, Uppsala University, Sweden 2Key Laboratory of Aquatic Biodiversity and Conservation, Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan, China 3Department of Molecular Evolution, Cell and Molecular Biology, Science for Life Laboratory, Biomedical Centre, Uppsala University, Sweden *Corresponding author: E-mail: [email protected], [email protected]; [email protected]. Accepted: August 18, 2014 Data deposition: The Acrasis kona mitochondrial genome sequence and annotation have been deposited at GenBank under the accession KJ679272. Downloaded from Abstract Discoba(Excavata)isanancientgroupof eukaryotes withgreatmorphological andecologicaldiversity.Unlikethe other major divisions http://gbe.oxfordjournals.org/ of Discoba (Jakobida and Euglenozoa), little is known about the mitochondrial DNAs (mtDNAs) of Heterolobosea. We have assembled a complete mtDNA genome from the aggregating heterolobosean amoeba, Acrasis kona, which consists of a single circular highly AT- rich (83.3%) molecule of 51.5 kb. Unexpectedly, A. kona mtDNA is missing roughly 40% of the protein-coding genes and nearly half of the transfer RNAs found in the only other sequenced heterolobosean mtDNAs, those of Naegleria spp. Instead, over a quarter of A. kona mtDNA consists of novel open reading frames. Eleven of the 16 protein-coding genes missing from A. kona mtDNA were identified in its nuclear DNA and polyA RNA, and phylogenetic analyses indicate that at least 10 of these 11 putative nuclear-encoded mitochondrial (NcMt) proteins arose by direct transfer from the mitochondrion. -
Nature Nurtures the Design of New Semi-Synthetic Macrolide Antibiotics
The Journal of Antibiotics (2017) 70, 527–533 OPEN Official journal of the Japan Antibiotics Research Association www.nature.com/ja REVIEW ARTICLE Nature nurtures the design of new semi-synthetic macrolide antibiotics Prabhavathi Fernandes, Evan Martens and David Pereira Erythromycin and its analogs are used to treat respiratory tract and other infections. The broad use of these antibiotics during the last 5 decades has led to resistance that can range from 20% to over 70% in certain parts of the world. Efforts to find macrolides that were active against macrolide-resistant strains led to the development of erythromycin analogs with alkyl-aryl side chains that mimicked the sugar side chain of 16-membered macrolides, such as tylosin. Further modifications were made to improve the potency of these molecules by removal of the cladinose sugar to obtain a smaller molecule, a modification that was learned from an older macrolide, pikromycin. A keto group was introduced after removal of the cladinose sugar to make the new ketolide subclass. Only one ketolide, telithromycin, received marketing authorization but because of severe adverse events, it is no longer widely used. Failure to identify the structure-relationship responsible for this clinical toxicity led to discontinuation of many ketolides that were in development. One that did complete clinical development, cethromycin, did not meet clinical efficacy criteria and therefore did not receive marketing approval. Work on developing new macrolides was re-initiated after showing that inhibition of nicotinic acetylcholine receptors by the imidazolyl-pyridine moiety on the side chain of telithromycin was likely responsible for the severe adverse events. -
Bacterial Brain Abscess in a Patient with Granulomatous Amebic Encephalitis
SVOA Neurology ISSN: 2753-9180 Case Report Bacterial Brain Abscess in a Patient with Granulomatous Amebic Encephalitis. A Misdiagnosis or Free-Living Amoeba Acting as Trojan Horse? Rolando Lovaton1* and Wesley Alaba1 1 Hospital Nacional Cayetano Heredia (Lima-Peru) *Corresponding Author: Dr. Rolando Lovaton, Neurosurgery Service-Hospital Nacional Cayetano Heredia, Avenida Honorio Delgado 262 San Martin de Porres, Lima-Peru Received: July 13, 2021 Published: July 24, 2021 Abstract Amebic encephalitis is a rare and devastating disease. Mortality rate is almost 90% of cases. Here is described a very rare case of bacterial brain abscess in a patient with recent diagnosis of granulomatous amebic encephalitis. Case De- scription: A 29-year-old woman presented with headache, right hemiparesis and tonic-clonic seizure. Patient was diag- nosed with granulomatous amebic encephalitis due to Acanthamoeba spp.; although, there was no improvement of symptoms in spite of stablished treatment. Three months after initial diagnosis, a brain MRI showed a ring-enhancing lesion in the left frontal lobe compatible with brain abscess. Patient was scheduled for surgical evacuation and brain abscess was confirmed intraoperatively. However, Gram staining of the purulent content showed gram-positive cocci. Patient improved headache and focal deficit after surgery. Conclusion: It is the first reported case of a patient with cen- tral nervous system infection secondary to Acanthamoeba spp. who presented a bacterial brain abscess in a short time. Keywords: amebic encephalitis; Acanthamoeba spp; bacterial brain abscess Introduction Free–living amoebae cause potentially fatal infection of central nervous system. Two clinical entities have been de- scribed for amebic encephalitis: primary amebic meningoencephalitis (PAM), and granulomatous amebic encephalitis (GAE). -
WHO Report on Surveillance of Antibiotic Consumption: 2016-2018 Early Implementation ISBN 978-92-4-151488-0 © World Health Organization 2018 Some Rights Reserved
WHO Report on Surveillance of Antibiotic Consumption 2016-2018 Early implementation WHO Report on Surveillance of Antibiotic Consumption 2016 - 2018 Early implementation WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation ISBN 978-92-4-151488-0 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution- NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons. org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non- commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. WHO report on surveillance of antibiotic consumption: 2016-2018 early implementation. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. -
In Vitro Activities of 11 Antimicrobial Agents Against Macrolide-Resistant
Jpn. J. Infect. Dis., 65, 535-538, 2012 Short Communication In Vitro Activities of 11 Antimicrobial Agents against Macrolide-Resistant Mycoplasma pneumoniae Isolates from Pediatric Patients: Results from a Multicenter Surveillance Study Hiroto Akaike1, Naoyuki Miyashita2*,MikaKubo1, Yasuhiro Kawai1, Takaaki Tanaka1, Satoko Ogita1, Kozo Kawasaki1, Takashi Nakano1,KiheiTerada1, Kazunobu Ouchi1, and the Atypical Pathogen Study Group** 1Department of Pediatrics and 2Department of Internal Medicine 1, Kawasaki Medical School, Okayama 700-8505, Japan (Received April 12, 2012. Accepted July 11, 2012) SUMMARY: Macrolide-resistant Mycoplasma pneumoniae is emerging in several countries, and it is mainly observed in children. To our knowledge, we conducted the first multicenter prospective epidemiological study of macrolide-resistant M. pneumoniae in order to investigate regional differences in the susceptibility of macrolide-resistant M. pneumoniae to antibacterial agents. The in vitro activities of 11 antimicrobial agents against macrolide-resistant M. pneumoniae isolates from 5 different areas of Japan were investigated. Among 190 M. pneumoniae isolates from pediatric patients, 124 (65.2z)iso- lates showed macrolide resistance and possessed an A2063G transition in domain V of the 23S rRNA. These isolates showed high resistance to erythromycin, clarithromycin, and azithromycin with minimum inhibitory concentrations (MICs) Æ16 mg/ml. Conversely, quinolones such as garenoxacin, moxifloxa- cin, tosufloxacin, and levofloxacin exhibited potent antimycoplasmal activity. No regional differences were observed with respect to the MICs among the 5 areas in Japan. Mycoplasma pneumoniae is a major causative patho- pneumonia isolates had mutations in domain V of the gen of respiratory tract infections, and it is found 23S rRNA gene (1,2,10,11). -
Studies of Laboratory Subcutaneous Infection of Naegleria Fowleri Carter, 1970 in Guinea Pigs| BCG Vaccination and Delayed Hypersensitivity
University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 1974 Studies of laboratory subcutaneous infection of Naegleria fowleri Carter, 1970 in guinea pigs| BCG vaccination and delayed hypersensitivity Peter Diffley The University of Montana Follow this and additional works at: https://scholarworks.umt.edu/etd Let us know how access to this document benefits ou.y Recommended Citation Diffley, Peter, "Studies of laboratory subcutaneous infection of Naegleria fowleri Carter, 1970 in guinea pigs| BCG vaccination and delayed hypersensitivity" (1974). Graduate Student Theses, Dissertations, & Professional Papers. 3697. https://scholarworks.umt.edu/etd/3697 This Thesis is brought to you for free and open access by the Graduate School at ScholarWorks at University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. STUDIES OP LABORATORY SUBCUTANEOUS INFECTION OF Naegleria fowleri CARTER, 1970 IN GUINEA PIGS:BOG VACCINATION AND DELAYED HYPERSENSITIVITY by Peter Diffley B.S., Tulane University, 1968 Presented in partial fulfillment of the requirements for the degree of Master of Science University of Montana 1974 Approved by: UMI Number: EP33846 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. UMT Dissertation Publishing UMI EP33846 Copyright 2012 by ProQuest LLC. -
Intracellular Penetration and Effects of Antibiotics On
antibiotics Review Intracellular Penetration and Effects of Antibiotics on Staphylococcus aureus Inside Human Neutrophils: A Comprehensive Review Suzanne Bongers 1 , Pien Hellebrekers 1,2 , Luke P.H. Leenen 1, Leo Koenderman 2,3 and Falco Hietbrink 1,* 1 Department of Surgery, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands; [email protected] (S.B.); [email protected] (P.H.); [email protected] (L.P.H.L.) 2 Laboratory of Translational Immunology, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands; [email protected] 3 Department of Pulmonology, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands * Correspondence: [email protected] Received: 6 April 2019; Accepted: 2 May 2019; Published: 4 May 2019 Abstract: Neutrophils are important assets in defense against invading bacteria like staphylococci. However, (dysfunctioning) neutrophils can also serve as reservoir for pathogens that are able to survive inside the cellular environment. Staphylococcus aureus is a notorious facultative intracellular pathogen. Most vulnerable for neutrophil dysfunction and intracellular infection are immune-deficient patients or, as has recently been described, severely injured patients. These dysfunctional neutrophils can become hide-out spots or “Trojan horses” for S. aureus. This location offers protection to bacteria from most antibiotics and allows transportation of bacteria throughout the body inside moving neutrophils. When neutrophils die, these bacteria are released at different locations. In this review, we therefore focus on the capacity of several groups of antibiotics to enter human neutrophils, kill intracellular S. aureus and affect neutrophil function. We provide an overview of intracellular capacity of available antibiotics to aid in clinical decision making.